-
Historical Archive
India in the drug war
From now on it will be able to produce the low cost Glivec, an anti-cancer product. Novartis, defeated: "This hinders research" It wants to be ...
Leggi » -
Historical Archive
WORLDNEWS: A judge declares the Pulmicort patent invalid in the United States
A US court has ruled that the patent protecting Pulmicort Respules, AstraZeneca's asthma drug in the United States…
Leggi » -
Historical Archive
Pani (Aifa): "Devolution no longer works for healthcare or pharmaceuticals"
37 revolutionary new molecules are coming. These are biotechnological molecules, monoclonal antibodies, based on biomarkers for hospital wards. I am…
Leggi » -
Historical Archive
Heparins return to the pharmacy. Aifa determines the suspension
"We were right." Thus Alfonso Misasi, national secretary of Federfarma comments on the decision of the Lazio TAR to suspend…
Leggi » -
Historical Archive
We need to encourage generics to research new drugs
Only two numbers, 2,600 against 175, are dollars and these numbers correspond to a month of treatment with…
Leggi » -
Historical Archive
WORLDNEWS: GREECE, multinationals block hundreds of DRUGS
In Grecia, la sanità è ormai in ginocchio, mancherebbero infatti farmaci per le malattie più gravi: dal diabete al cancro.Secondo…
Leggi » -
Historical Archive
The smartass of Big Pharma
Quella del Glivec è una vecchia storia che non riguarda solo i rapporti tra uno Stato tra i più importanti…
Leggi » -
Historical Archive
India, yes to low-cost anti-cancer. Novartis loses patent appeal
Dopo sei anni di battaglia legale la Corte Suprema indiana ha respinto l’istanza dell’industria farmaceutica svizzera per il brevetto di…
Leggi » -
Historical Archive
HAPPY EASTER LETTER from PATRIZIO MONDI'
"Buona Pasqua a tutti i componenti della nostra associazione, ed alle rispettive famiglie. Patrizio Mondì" …
Leggi » -
Historical Archive